T-lymphoid blast crisis in chronic myeloid leukemia. 1991

S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
Department of Medical Oncology, Tata Memorial Hospital, Parel, Bombay, India.

Chronic myeloid leukemia (CML) is considered to be a pleuripotential stem cell disorder with the capacity to differentiate into myeloid, erythroid, megakaryocytic, and lymphoid cell lines. Consequently, blast crisis (BC) involving each of the above lineages has been well described. Among lymphoblastic crises, differentiation frequently occurs along B-cell lineage. We report four patients of CML who terminated in T-cell extramedullary BC in lymph nodes after a variable duration of chronic phase. The T-lineage was established by characteristic cytochemical staining and reactivity with a panel of anti-T-cell monoclonal antibodies. All four cases were Philadelphia (Ph) chromosome positive and demonstrated the Ph chromosome and associated anomalies (extra Ph, +19) in the lymph nodes. Our data adds to the growing evidence that CML is a disorder of the common stem cell from which T, B, and myeloid precursors originate.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
January 2014, European journal of haematology,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
November 1985, Blood,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
January 1991, Leukemia & lymphoma,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
June 1982, Tumori,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
May 1987, European journal of cancer & clinical oncology,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
October 2000, Leukemia & lymphoma,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
March 2015, Hematology/oncology and stem cell therapy,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
December 1995, Leukemia & lymphoma,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
November 1977, British medical journal,
S H Advani, and H Malhotra, and P R Kadam, and R S Iyer, and G Nanjangud, and B Balsara, and T Saikia, and R Gopal, and C N Nair
January 1983, Folia haematologica (Leipzig, Germany : 1928),
Copied contents to your clipboard!